Medical News

RSS

Scientists identify molecular mechanism of muscle stem cell differentiation

Under normal circumstances, adult stem cells reside in muscle tissue, where they can differentiate into a number of different cell types. After an injury (or even a tough workout), muscles are inflamed as cells and molecules flood the area to control damage and begin repairs. When called upon to replace muscle tissue damaged by injury or genetic disease, some muscle stem cells differentiate, becoming new muscle cells, while others make more stem cells. At Sanford-Burnham Medical Research Institute (Sanford-Burnham), a team of scientists led by Pier Lorenzo Puri, M.D., Ph.D., recently uncovered the molecular messengers that translate inflammatory signals into the genetic changes that tell muscle stem cells to differentiate.

11 Oct 2010

Aetna, other insurers develop plans to help cut costs

Health insurer Aetna Inc. is developing plans to pay a major San Diego medical group enhanced fees for providing extra services to keep patients healthier, and to share any resulting cost savings.

11 Oct 2010

Infinity announces preliminary results of IPI-926 Phase 1 study in patients with solid tumors

Infinity Pharmaceuticals, Inc. today announced promising preliminary results from a Phase 1 study of IPI-926, its novel, oral small molecule that targets the Hedgehog pathway.

11 Oct 2010

Administration's waivers of health law raise questions about 'mini-med' plans

The White House on Thursday defended granting waivers to some employers from a key provision of the new health care law, saying it was the best way to keep people insured until the law fully takes effect.

11 Oct 2010

Cytomedix secures $13 million in registered direct offering under equity purchase agreements

Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, announced today that the Company has secured approximately $13 million in current and future funding via a registered direct offering and commitments under two separate equity purchase agreements.

11 Oct 2010

IntegenX receives DTRA contract to develop ISS system for rapid detection of emerging pathogens

IntegenX, Inc. today announced that it has been awarded a new contract by the Defense Threat Reduction Agency (DTRA) of the U.S. Department of Defense (DoD) to develop an Integrated Sample-to-Sequence (ISS) system for rapid detection and identification of genetically engineered bacteria and viruses, medically relevant bacteria and viruses, and emerging pathogens.

11 Oct 2010

Research may offer new therapy targets for drug-resistant breast tumors

Researchers at the University of Illinois at Chicago College of Medicine have found how gene expression that may contribute to drug resistance is ramped up in unusual types of breast tumors. Their findings may offer new therapy targets.

11 Oct 2010

Cell Cure to receive equity investment of $7.1 million to develop stem cell-based therapies

BioTime, Inc. Cell Cure Neurosciences Ltd., and Hadasit Bio-Holdings Ltd. jointly announced today that Cell Cure will receive an equity investment of $7.1 million from BioTime, Teva Pharmaceutical Industries Ltd., and Hadasit Bio-Holdings (HBL).

11 Oct 2010

Are 'mini-med' plan waivers a good idea?

Kaiser Health News staff writer Andrew Villegas asks two experts with differing views whether it was a good idea for the Obama administration to grant one-year waivers to about 30 insurers, employers and union health plans to continue offering what are dubbed "mini-med" insurance plans.

11 Oct 2010

Anti-HER2 antibody-drug conjugate effective as first-line therapy for advanced breast cancer: Research

A new type of breast cancer treatment has shown encouraging activity as a first-line therapy in HER2-positive metastatic disease, researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.

11 Oct 2010

Discovery can lead to new approach for treating MS in early stages

A deficiency in one of the immune system's enzymes affects the severity of autoimmune diseases such as MS, and explains why the course of these diseases can vary so much. New findings give an insight into how this enzyme deficiency can be diagnosed, and could lead to new medicines, reveals a thesis from the Sahlgrenska Academy.

11 Oct 2010

Cell Cure, Teva Pharmaceutical enter license option agreement for OpRegen product

BioTime, Inc., Cell Cure Neurosciences Ltd., and Hadasit Bio-Holdings Ltd. jointly announced today that Cell Cure and Teva Pharmaceutical Industries Ltd. have entered into an exclusive license option agreement to develop and commercialize Cell Cure's OpRegen product for the treatment of age-related macular degeneration (AMD).

11 Oct 2010

Opinions: Learning to live with malaria; U.S. food aid policy; foreign aid reform

Recent discoveries of a possible wild reservoir for humankind's most malignant malaria, some 130 years after the discovery of the malaria parasite, could mean that it will be impossible to eradicate malaria,Sonia Shah, the author of The Fever, How Malaria Has Ruled Humankind for 500,000 Years,observes in an International Herald Tribune opinion piece.

11 Oct 2010

Political Ads, rhetoric on health law heating up races in Alaska, Nevada, Pennsylvania

Alaska Senate candidate Joe Miller said this week that his family took benefits years ago from Medicaid and a state program for low-income children and pregnant women despite his criticism of entitlement programs, The Associated Press reports.

11 Oct 2010

Meridia – weight loss pill off the shelves in US

Abbott Pharmaceuticals has announced the withdrawal of weight loss drug Meridia from shelves in the United States and urged patients to stop taking it after regulators questioned its safety. The withdrawal happened last Friday in the US. In January, Meridia sales were suspended in Europe.

10 Oct 2010

Bathing better than pethidine as pain relief during labor: Survey

According to a large survey of new mothers, a bath or a shower relieves pain in childbirth more effectively than anaesthetic gas or pethidine. The survey also found that breathing techniques, massage, hot packs and hypnotherapy were more effective than pethidine, a strong analgesic given by injection, and nitrous oxide, that is an anaesthetic gas. The survey has renewed the debate of drug overuse during child birth that could potentially harm babies.

10 Oct 2010

Some herbal remedies for anxiety disorders effective

Two herbal remedies from passion flower extract and kava have shown to be effective in alleviating anxiety say scientists. The results came from an analysis of 24 studies involving more than 2,000 participants which also showed that combinations of the amino acids L-lysine and L-arginine may be useful anxiety remedies.

10 Oct 2010

“Black Death” of the Middle ages blamed on bacteria

Black Death or plague that killed an estimated one-third of Europe's population in the Middle Ages has been ascribed to a bacteria called Yersinia pestis by anthropologists.

10 Oct 2010

Weight loss pill off shelves due to heart attack risk

Final verdict on a popular weight loss drug Reductil is to be delivered today. It is being debated whether the pill should be taken off the shelves in Australia and New Zealand. The drug Sibutramine sold as Reductil is linked to increased risk of heart attacks.

10 Oct 2010

Integra LifeSciences to feature Inforce Reinforcement Matrix at ASSH Annual Meeting

Integra LifeSciences Holdings Corporation announced today that it is featuring the Inforce Reinforcement Matrix at the 65th Annual Meeting of the American Society for Surgery of the Hand (ASSH) on October 7-9, in Boston, Massachusetts.

8 Oct 2010

Medical News

Scientists identify molecular mechanism of muscle stem cell differentiation

Aetna, other insurers develop plans to help cut costs

Infinity announces preliminary results of IPI-926 Phase 1 study in patients with solid tumors

Administration's waivers of health law raise questions about 'mini-med' plans

Cytomedix secures $13 million in registered direct offering under equity purchase agreements

IntegenX receives DTRA contract to develop ISS system for rapid detection of emerging pathogens

Research may offer new therapy targets for drug-resistant breast tumors

Cell Cure to receive equity investment of $7.1 million to develop stem cell-based therapies

Are 'mini-med' plan waivers a good idea?

Anti-HER2 antibody-drug conjugate effective as first-line therapy for advanced breast cancer: Research

Discovery can lead to new approach for treating MS in early stages

Cell Cure, Teva Pharmaceutical enter license option agreement for OpRegen product

Opinions: Learning to live with malaria; U.S. food aid policy; foreign aid reform

Political Ads, rhetoric on health law heating up races in Alaska, Nevada, Pennsylvania

Meridia – weight loss pill off the shelves in US

Bathing better than pethidine as pain relief during labor: Survey

Some herbal remedies for anxiety disorders effective

“Black Death” of the Middle ages blamed on bacteria

Weight loss pill off shelves due to heart attack risk

Integra LifeSciences to feature Inforce Reinforcement Matrix at ASSH Annual Meeting

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News